Procoagulant imbalance aggravated with falling liver function reserve, but not associated with the presence of portal vein thrombosis in cirrhosis

European Journal of Gastroenterology and Hepatology

Volumn 27, Issue 6, 2015, Pages 672-678

  Tang, Wen ^a   Wang, Yu ^a   Zhao, Xinyan ^a   Wang, Xiaoming ^a   Zhang, Tao ^a   Ou, Xiaojuan ^a   Shou, Weiling ^b   You, Hong ^a   Jia, Jidong ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

Author keywords

antithrombin; liver cirrhosis; portal vein thrombosis; protein C; thrombin generation

Indexed keywords

ANTICOAGULANT AGENT; ANTITHROMBIN; BLOOD CLOTTING FACTOR 8; PROCOAGULANT; PROTEIN C; PROTEIN S; F8 PROTEIN, HUMAN;

ADOLESCENT; AGED; ARTICLE; BLOOD CLOTTING; CHILD PUGH SCORE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; DOPPLER FLOWMETRY; FEMALE; HUMAN; HYPERCOAGULABILITY; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; PORTAL VEIN THROMBOSIS; PRIORITY JOURNAL; SCLEROTHERAPY; SPLENECTOMY; STRATIFICATION; THROMBIN TIME; ADULT; BLOOD; COMPLICATION; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY; PORTAL VEIN; SEVERITY OF ILLNESS INDEX; THROMBOPHILIA; THROMBOSIS; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ANTITHROMBINS; FACTOR VIII; FEMALE; HUMANS; LIVER CIRRHOSIS; MALE; MIDDLE AGED; PORTAL VEIN; PROTEIN C; PROTEIN S; SEVERITY OF ILLNESS INDEX; THROMBOPHILIA; THROMBOSIS;

EID: 84947126832     PISSN: 0954691X     EISSN: 14735687     Source Type: Journal    
DOI: 10.1097/MEG.0000000000000352     Document Type: Article

References (27)

1. Qi X, Bai M, Yang Z, Yuan S, Zhang C, Han G, Fan D. Occlusive portal vein thrombosis as a new marker of decompensated cirrhosis. Med Hypotheses 2011; 76:522-526.
2. Zhang D, Hao J, Yang N. Protein C and D-dimer are related to portal vein thrombosis in patients with liver cirrhosis. J Gastroenterol Hepatol 2010; 25:116-121.
3. Zhang DL, Hao JY, Yang N. Value of D-dimer and protein S for diagnosis of portal vein thrombosis in patients with liver cirrhosis. J Int Med Res 2013; 41:664-672.
4. Kawanaka H, Akahoshi T, Kinjo N, Konishi K, Yoshida D, Anegawa G, et al. Impact of antithrombin III concentrates on portal vein thrombosis after splenectomy in patients with liver cirrhosis and hypersplenism. Ann Surg 2010; 251:76-83.
5. Zocco MA, Di Stasio E, De Cristofaro R, Novi M, Ainora ME, Ponziani F, et al. Thrombotic risk factors in patients with liver cirrhosis: Correlation with MELD scoring system and portal vein thrombosis development. J Hepatol 2009; 51:682-689.
6. Martinelli I, Primignani M, Aghemo A, Reati R, Bucciarelli P, Fabris F, et al. High levels of factor VIII and risk of extra-hepatic portal vein obstruction. J Hepatol 2009; 50:916-922.
7. Werner KT, Sando S, Carey EJ, Vargas HE, Byrne TJ, Douglas DD, et al. Portal vein thrombosis in patients with end stage liver disease awaiting liver transplantation: Outcome of anticoagulation. Dig Dis Sci 2013; 58:1776-1780.
8. Fimognari FL, De Santis A, Piccheri C, Moscatelli R, Gigliotti F, Vestri A, et al. Evaluation of D-dimer and factor VIII in cirrhotic patients with asymptomatic portal venous thrombosis. J Lab Clin Med 2005; 146:238-243.
9. Qi X, Chen H, Han G. Effect of antithrombin, protein C and protein S on portal vein thrombosis in liver cirrhosis: A meta-analysis. Am J Med Sci 2013; 346:38-44.
10. Chen H, Qi X, He C, Yin Z, Fan D, Han G. Coagulation imbalance may not contribute to the development of portal vein thrombosis in patients with cirrhosis. Thromb Res 2013; 131:173-177.
11. Tripodi A, Mannucci PM. The coagulopathy of chronic liver disease. N Engl J Med 2011; 365:147-156.
12. Lisman T, Caldwell SH, Burroughs AK, Northup PG, Senzolo M, Stravitz RT, et al. Hemostasis and thrombosis in patients with liver disease: The ups and downs. J Hepatol 2010; 53:362-371.
13. Chantarangkul V, Clerici M, Bressi C, Giesen PL, Tripodi A. Thrombin generation assessed as endogenous thrombin potential in patients with hyper-or hypo-coagulability. Haematologica 2003; 88:547-554.
14. Lisman T, Bakhtiari K, Pereboom IT, Hendriks HG, Meijers JC, Porte RJ. Normal to increased thrombin generation in patients undergoing liver transplantation despite prolonged conventional coagulation tests. J Hepatol 2010; 52:355-361.
15. Tripodi A, Primignani M, Chantarangkul V, Dell'Era A, Clerici M, De Franchis R, et al. An imbalance of pro-vs anti-coagulation factors in plasma from patients with cirrhosis. Gastroenterology 2009; 137:2105-2111.
16. Tripodi A, Primignani M, Lemma L, Chantarangkul V, Dell'Era A, Iannuzzi F, et al. Detection of the imbalance of procoagulant versus anticoagulant factors in cirrhosis by a simple laboratory method. Hepatology 2010; 52:249-255.
17. Tripodi A, Legnani C, Lemma L, Cosmi B, Palareti G, Chantarangkul V, Mannucci PM. Abnormal Protac-induced coagulation inhibition chromogenic assay results are associated with an increased risk of recurrent venous thromboembolism. J Thromb Thrombolysis 2010; 30:215-219.
18. Chaireti R, Rajani R, Bergquist A, Melin T, Friis-Liby IL, Kapraali M, et al. Increased thrombin generation in splanchnic vein thrombosis is related to the presence of liver cirrhosis and not to the thrombotic event. Thromb Res 2014; 134:455-461.
19. Nery F, Chevret S, Condat B, De Raucourt E, Boudaoud L, Rautou PE, et al. Causes and consequences of portal vein thrombosis in 1243 patients with cirrhosis: Results of a longitudinal study. Hepatology 2015; 61:660-667.
20. Qi X, De Stefano V, Li H, Dai J, Guo X, Fan D. Anticoagulation for the treatment of portal vein thrombosis in liver cirrhosis: A systematic review and meta-analysis of observational studies. Eur J Intern Med 2015; 26:23-29.
21. Qi X, Han G, Fan D. Management of portal vein thrombosis in liver cirrhosis. Nat Rev Gastroenterol Hepatol 2014; 11:435-446.
22. Tsochatzis EA, Senzolo M, Germani G, Gatt A, Burroughs AK. Systematic review: Portal vein thrombosis in cirrhosis. Aliment Pharmacol Ther 2010; 31:366-374.
23. Maruyama H, Okugawa H, Takahashi M, Yokosuka O. De novo portal vein thrombosis in virus-related cirrhosis: Predictive factors and longterm outcomes. Am J Gastroenterol 2013; 108:568-574.
24. Qi XS, Bai M, Fan DM. Nonselective beta-blockers may induce development of portal vein thrombosis in cirrhosis. World J Gastroenterol 2014; 20:11463-11466.
25. Qi X, Zhang C, Han G, Zhang W, He C, Yin Z, et al. Prevalence of the JAK2V617F mutation in Chinese patients with Budd-Chiari syndrome and portal vein thrombosis: A prospective study. J Gastroenterol Hepatol 2012; 27:1036-1043.
26. Qi X, Ren W, De Stefano V, Fan D. Associations of coagulation factor V Leiden and prothrombin G20210A mutations with Budd-Chiari syndrome and portal vein thrombosis: A systematic review and metaanalysis. Clin Gastroenterol Hepatol 2014; 12:1801.e7-1812.e7.
27. Toulon P, Smirnov M, Triscott M, Safa O, Biguzzi E, Bouziane K, Tripodi A. A new chromogenic assay (HemosIL ThromboPath) is sensitive to major prothrombotic risk factors affecting the protein C pathway. Results of a multicenter study. Thromb Res 2009; 124:137-143.